Mitochondria in AD patients have been observed to reveal significant structural damage together with decreases in mitochondrial fusion proteins, increases in Fis1, and increases in Ser616 phosphorylated Drp1 (despite decreases in total Drp1)—all of which favor excessive fragmentation [178, 179]. This evidence concerns the gene DNM1L and Alzheimer disease.